ArticleThe lancet. HIV2025

Safety and pharmacokinetics of N6LS, a broadly neutralising monoclonal antibody for HIV: a phase 1, open-label, dose-escalation study in healthy adults.

Richard L Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.